相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dose-Escalation Study of Systemically Delivered rAAVrh74.MHCK7.micro-dystrophin in the mdx Mouse Model of Duchenne Muscular Dystrophy
Rachael A. Potter et al.
HUMAN GENE THERAPY (2021)
Synthetic Biology: Emerging Concepts to Design and Advance Adeno-Associated Viral Vectors for Gene Therapy
Hanna J. Wagner et al.
ADVANCED SCIENCE (2021)
Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species
Mohammadsharif Tabebordbar et al.
CELL (2021)
The clinical course of Duchenne muscular dystrophy in the corticosteroid treatment era: a systematic literature review
Shelagh M. Szabo et al.
ORPHANET JOURNAL OF RARE DISEASES (2021)
Silence superoxide dismutase 1 (SOD1): a promising therapeutic target for amyotrophic lateral sclerosis (ALS)
Elena Abati et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2020)
AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer
Helena Costa Verdera et al.
MOLECULAR THERAPY (2020)
Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy A Nonrandomized Controlled Trial
Jerry R. Mendell et al.
JAMA NEUROLOGY (2020)
Long-Term Efficacy of AAV9-U7snRNA-Mediated Exon 51 Skipping in mdx52 Mice
Philippine Aupy et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
Broader Implications of Progressive Liver Dysfunction and Lethal Sepsis in Two Boys following Systemic High-Dose AAV
Leon Morales et al.
MOLECULAR THERAPY (2020)
After Third Death, Audentes' AT132 Remains on Clinical Hold
Alex Philippidis
HUMAN GENE THERAPY (2020)
Adeno-associated virus vector as a platform for gene therapy delivery
Dan Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Onasemnogene Abeparvovec: First Global Approval
Sheridan M. Hoy
DRUGS (2019)
Intrathecal administration of onasemnogene abeparvovec gene-replacement therapy (GRT) for spinal muscular atrophy type 2 (SMA2): phase 1/2a study (STRONG)
R. Finkel et al.
NEUROMUSCULAR DISORDERS (2019)
Comprehensive AAV capsid fitness landscape reveals a viral gene and enables machine-guided design
Pierce J. Ogden et al.
SCIENCE (2019)
Utrophin up-regulation by artificial transcription factors induces muscle rescue and impacts the neuromuscular junction in mdx mice
Cinzia Pisani et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy
Dongsheng Duan
MOLECULAR THERAPY (2018)
Emerging Issues in AAV-Mediated In Vivo Gene Therapy
Pasqualina Colella et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
S/MAR Element Facilitates Episomal Long-Term Persistence of Adeno-Associated Virus Vector Genomes in Proliferating Cells
Claudia Hagedorn et al.
HUMAN GENE THERAPY (2017)
LONG-TERM EFFECTS OF SYSTEMIC GENE THERAPY IN A CANINE MODEL OF MYOTUBULAR MYOPATHY
Matthew Elverman et al.
MUSCLE & NERVE (2017)
Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
J. R. Mendell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant
L. A. George et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Structure-guided evolution of antigenically distinct adeno-associated virus variants for immune evasion
Longping Victor Tse et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy
Caroline Le Guiner et al.
NATURE COMMUNICATIONS (2017)
Neurodevelopmental, emotional, and behavioural problems in Duchenne muscular dystrophy in relation to underlying dystrophin gene mutations
Valeria Ricotti et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2016)
Corticosteroids for the treatment of Duchenne muscular dystrophy
Emma Matthews et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2016)
Safe and bodywide muscle transduction in young adult Duchenne muscular dystrophy dogs with adeno-associated virus
Yongping Yue et al.
HUMAN MOLECULAR GENETICS (2015)
A Phase 1/2a Follistatin Gene Therapy Trial for Becker Muscular Dystrophy
Jerry R. Mendell et al.
MOLECULAR THERAPY (2015)
Duchenne Muscular Dystrophy: From Diagnosis to Therapy
Maria Sofia Falzarano et al.
MOLECULES (2015)
Immune-mediated pathology in Duchenne muscular dystrophy
Amy S. Rosenberg et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Evaluation of Readministration of a Recombinant Adeno-Associated Virus Vector Expressing Acid Alpha-Glucosidase in Pompe Disease: Preclinical to Clinical Planning
Manuela Corti et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2015)
The Dystrophin Complex: Structure, Function, and Implications for Therapy
Quan Q. Gao et al.
COMPREHENSIVE PHYSIOLOGY (2015)
Differential Adeno-Associated Virus Serotype-Specific Interaction Patterns with Synthetic Heparins and Other Glycans
Mario Mietzsch et al.
JOURNAL OF VIROLOGY (2014)
Vascular Delivery of rAAVrh74.MCK.GALGT2 to the Gastrocnemius Muscle of the Rhesus Macaque Stimulates the Expression of Dystrophin and Laminin α2 Surrogates
Louis G. Chicoine et al.
MOLECULAR THERAPY (2014)
Plasmapheresis Eliminates the Negative Impact of AAV Antibodies on Microdystrophin Gene Expression Following Vascular Delivery
L. G. Chicoine et al.
MOLECULAR THERAPY (2014)
Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B
A. C. Nathwani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Feasibility and Safety of Systemic rAAV9-hNAGLU Delivery for Treating Mucopolysaccharidosis IIIB: Toxicology, Biodistribution, and Immunological Assessments in Primates
Darren A. Murrey et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2014)
Contribution of oxidative stress to pathology in diaphragm and limb muscles with Duchenne muscular dystrophy
Jong-Hee Kim et al.
JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY (2013)
Analysis of Transduction Efficiency, Tropism and Axonal Transport of AAV Serotypes 1, 2, 5, 6, 8 and 9 in the Mouse Brain
Dominik F. Aschauer et al.
PLOS ONE (2013)
Hybrid Adeno-Associated Viral Vectors Utilizing Transposase-Mediated Somatic Integration for Stable Transgene Expression in Human Cells
Wenli Zhang et al.
PLOS ONE (2013)
Overcoming Preexisting Humoral Immunity to AAV Using Capsid Decoys
Federico Mingozzi et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in >21-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy
Brian Bostick et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
Muscle Function Recovery in Golden Retriever Muscular Dystrophy After AAV1-U7 Exon Skipping
Adeline Vulin et al.
MOLECULAR THERAPY (2012)
Phase 1 Gene Therapy for Duchenne Muscular Dystrophy Using a Translational Optimized AAV Vector
Dawn E. Bowles et al.
MOLECULAR THERAPY (2012)
The AAV Vector Toolkit: Poised at the Clinical Crossroads
Aravind Asokan et al.
MOLECULAR THERAPY (2012)
Myocardial gene delivery using molecular cardiac surgery with recombinant adeno-associated virus vectors in vivo
J. D. White et al.
GENE THERAPY (2011)
Terminal N-Linked Galactose Is the Primary Receptor for Adeno-associated Virus 9
Shen Shen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Genotype and phenotype characterization in a large dystrophinopathic cohort with extended follow-up
Francesca Magri et al.
JOURNAL OF NEUROLOGY (2011)
Preclinical Differences of Intravascular AAV9 Delivery to Neurons and Glia: A Comparative Study of Adult Mice and Nonhuman Primates
Steven J. Gray et al.
MOLECULAR THERAPY (2011)
AAV-microdystrophin Therapy Improves Cardiac Performance in Aged Female mdx Mice
Brian Bostick et al.
MOLECULAR THERAPY (2011)
Long-term Safety and Efficacy Following Systemic Administration of a Self-complementary AAV Vector Encoding Human FIX Pseudotyped With Serotype 5 and 8 Capsid Proteins
Amit C. Nathwani et al.
MOLECULAR THERAPY (2011)
Human Hepatocyte Growth Factor Receptor Is a Cellular Coreceptor for Adeno-Associated Virus Serotype
Chen Ling et al.
HUMAN GENE THERAPY (2010)
The artificial gene Jazz, a transcriptional regulator of utrophin, corrects the dystrophic pathology in mdx mice
Maria Grazia Di Certo et al.
HUMAN MOLECULAR GENETICS (2010)
Persistent Expression of FLAG-tagged Micro-dystrophin in Nonhuman Primates Following Intramuscular and Vascular Delivery
Louise R. Rodino-Klapac et al.
MOLECULAR THERAPY (2010)
Widespread Muscle Expression of an AAV9 Human Mini-dystrophin Vector After Intravenous Injection in Neonatal Dystrophin-deficient Dogs
Joe N. Kornegay et al.
MOLECULAR THERAPY (2010)
Epidermal growth factor receptor is a co-receptor for adeno-associated virus serotype 6
Melodie L. Weller et al.
NATURE MEDICINE (2010)
Brief Report: Dystrophin Immunity in Duchenne's Muscular Dystrophy.
Jerry R. Mendell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy
Glenn P. Niemeyer et al.
BLOOD (2009)
Intravenous Administration of Self-complementary AAV9 Enables Transgene Delivery to Adult Motor Neurons
Sandra Duque et al.
MOLECULAR THERAPY (2009)
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
Kevin D. Foust et al.
NATURE BIOTECHNOLOGY (2009)
Follistatin Gene Delivery Enhances Muscle Growth and Strength in Nonhuman Primates
Janaiah Kota et al.
SCIENCE TRANSLATIONAL MEDICINE (2009)
A Single Intravenous Injection of Adeno-associated Virus Serotype-9 Leads to Whole Body Skeletal Muscle Transduction in Dogs
Yongping Yue et al.
MOLECULAR THERAPY (2008)
Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin/utrophin-deficient mice
Guy L. Odom et al.
MOLECULAR THERAPY (2008)
Systemic microdystrophin gene delivery improves skeletal muscle structure and function in old dystrophic mdx mice
Paul Gregorevic et al.
MOLECULAR THERAPY (2008)
Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy
Douglas P. Millay et al.
NATURE MEDICINE (2008)
Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle
Maja Z. Salva et al.
MOLECULAR THERAPY (2007)
Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression
Zejing Wang et al.
MOLECULAR THERAPY (2007)
Immunity to adeno-associated virus-mediated gene transfer in a random-bred canine model of Duchenne muscular dystrophy
Zejing Wang et al.
HUMAN GENE THERAPY (2007)
The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9
Bassel Akache et al.
JOURNAL OF VIROLOGY (2006)
Adeno-associated virus type 2 contains an integrin α5β1 binding domain essential for viral cell entry
Aravind Asokan et al.
JOURNAL OF VIROLOGY (2006)
Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo
Christina A. Pacak et al.
CIRCULATION RESEARCH (2006)
rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice
Paul Gregorevic et al.
NATURE MEDICINE (2006)
Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice
C. Riviere et al.
GENE THERAPY (2006)
Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart
Z Wang et al.
NATURE BIOTECHNOLOGY (2005)
Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection
Y Kashiwakura et al.
JOURNAL OF VIROLOGY (2005)
Adeno-associated virus and the development of adeno-associated virus vectors: A historical perspective
BJ Carter
MOLECULAR THERAPY (2004)
Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6
MJ Blankinship et al.
MOLECULAR THERAPY (2004)
Identification of PDGFR as a receptor for AAV-5 transduction
G Di Pasquale et al.
NATURE MEDICINE (2003)
Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product
K Yuasa et al.
GENE THERAPY (2002)
Adeno-associated virus vectors for gene transfer to the brain
T Okada et al.
METHODS (2002)
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
GP Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Adeno-associated virus vector-mediated minidystrophin gene therapy improves dystrophic muscle contractile function in mdx mice
J Watchko et al.
HUMAN GENE THERAPY (2002)
Adeno-associated virus vector gene transfer and sarcolemmal expression of a 144 kDa micro-dystrophin effectively restores the dystrophin-associated protein complex and inhibits myofibre degeneration in nude/mdx mice
SA Fabb et al.
HUMAN MOLECULAR GENETICS (2002)
Overexpression of the CT GalNAc transferase in skeletal muscle alters myofiber growth, neuromuscular structure, and laminin expression
B Xia et al.
DEVELOPMENTAL BIOLOGY (2002)
Development and characterization of an antisense-mediated prepackaging cell line for adeno-associated virus vector production
T Okada et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo
H Nakai et al.
JOURNAL OF VIROLOGY (2001)
Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy
M Sander et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model
B Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Adeno-associated virus-based vectors in gene therapy
J Tal
JOURNAL OF BIOMEDICAL SCIENCE (2000)
分享论文
